| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Aug―23 |
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19 |
Kanal Singh, Joseph M. Rocco, Veronique Nussenblatt |
| 2 |
[GO] |
2023―Mar―29 |
Report of Consensus Panel 5 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on COVID-19 Prophylaxis and Management. |
E. Terpos, A.R. Branagan, R. García-Sanz, J. Trotman, L.M. Greenberger, D.M. Stephens, et al. (+8) P. Morel, E. Kimby, A.M. Frustaci, E. Hatjiharissi, J. San-Miguel, M.A. Dimopoulos, S.P. Treon, V. Leblond |
| 3 |
[GO] |
2022―Dec―30 |
Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies |
Adrian Wiestner |
| 4 |
[GO] |
2022―Nov―19 |
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies |
S. Haggenburg, Q. Hofsink, C.E. Rutten, I.S. Nijhof, M.D. Hazenberg, A. Goorhuis |
| 5 |
[GO] |
2021―Jul―24 |
Iron metabolism in infections: Focus on COVID-19 |
Domenico Girelli, Giacomo Marchi, Fabiana Busti, Alice Vianello |
|
